15-77070951-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005724.6(TSPAN3):c.4G>A(p.Gly2Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000299 in 1,438,256 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
TSPAN3
NM_005724.6 missense
NM_005724.6 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 1.28
Genes affected
TSPAN3 (HGNC:17752): (tetraspanin 3) The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. The use of alternate polyadenylation sites has been found for this gene. Multiple alternative transcripts encoding different isoforms have been described. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.33935326).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPAN3 | NM_005724.6 | c.4G>A | p.Gly2Ser | missense_variant | 1/7 | ENST00000267970.9 | NP_005715.1 | |
TSPAN3 | NM_198902.3 | c.4G>A | p.Gly2Ser | missense_variant | 1/6 | NP_944492.1 | ||
TSPAN3 | NM_001168412.2 | c.4G>A | p.Gly2Ser | missense_variant | 1/6 | NP_001161884.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPAN3 | ENST00000267970.9 | c.4G>A | p.Gly2Ser | missense_variant | 1/7 | 1 | NM_005724.6 | ENSP00000267970 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151814Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
151814
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000248 AC: 2AN: 80664Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 45530
GnomAD3 exomes
AF:
AC:
2
AN:
80664
Hom.:
AF XY:
AC XY:
0
AN XY:
45530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000249 AC: 32AN: 1286442Hom.: 0 Cov.: 30 AF XY: 0.0000252 AC XY: 16AN XY: 634606
GnomAD4 exome
AF:
AC:
32
AN:
1286442
Hom.:
Cov.:
30
AF XY:
AC XY:
16
AN XY:
634606
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000725 AC: 11AN: 151814Hom.: 0 Cov.: 32 AF XY: 0.0000809 AC XY: 6AN XY: 74170
GnomAD4 genome
AF:
AC:
11
AN:
151814
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74170
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.4G>A (p.G2S) alteration is located in exon 1 (coding exon 1) of the TSPAN3 gene. This alteration results from a G to A substitution at nucleotide position 4, causing the glycine (G) at amino acid position 2 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;.
MutationTaster
Benign
D;D;D;D;N;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;D;N
REVEL
Benign
Sift
Pathogenic
D;D;D;D
Sift4G
Uncertain
D;D;D;T
Polyphen
D;.;.;.
Vest4
MutPred
Gain of glycosylation at G2 (P = 0.0494);Gain of glycosylation at G2 (P = 0.0494);Gain of glycosylation at G2 (P = 0.0494);Gain of glycosylation at G2 (P = 0.0494);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at